A two-stage study on multiple sclerosis susceptibility and chromosome 2q33

Area of Science:

• Genetics
• Neuroimmunology
• Human Disease Genetics

Background:

• Multiple sclerosis (MS) is a complex autoimmune disease affecting the central nervous system.
• Genetic factors play a significant role in MS susceptibility, but the underlying genetic architecture remains incompletely understood.
• Previous studies have implicated the CTLA4 gene region on chromosome 2q33 in MS risk.

Purpose of the Study:

• To investigate the association of genetic polymorphisms on chromosome 2q33 with multiple sclerosis (MS) in a Finnish cohort.
• To identify novel MS susceptibility genes in the 2q33 region, particularly outside the CTLA4 locus.

Main Methods:

• A two-stage genetic association study was conducted using 134 Finnish MS families in stage 1 and 186 MS families in stage 2.
• Seventeen genetic markers on chromosome 2q33 were analyzed for association with MS.
• Statistical analyses were performed to identify significant allelic and haplotype associations, considering subgroups based on HLA-DR2 status and geographic origin.

Main Results:

• No significant allelic or haplotype associations were found with the CTLA4 gene.
• A weak association signal was detected for a putative gene proximal to CTLA4, linked to marker rs3977, specifically in families without HLA-DR2 (P=0.02).
• Another independent association signal was identified for a distal gene, linked to marker D2S1271, in families from a high-risk region in western Finland (P=0.02).

Conclusions:

• The study provides preliminary evidence for two distinct MS susceptibility genes located on chromosome 2q33, independent of CTLA4.
• These findings suggest that genetic loci outside the previously implicated CTLA4 region contribute to MS risk.
• Further research is warranted to confirm and characterize these novel MS susceptibility genes.